Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GPR65 is a proton-sensing G protein-coupled receptor predominantly expressed in lymphoid tissues, retina, and vagal afferents. It is activated by acidic extracellular pH, leading to increased intracellular cAMP via Gs protein activation. GPR65 plays a role in immune modulation, cardioprotection post-myocardial infarction, neuroprotection in the retina and central nervous system, and other physiological processes. It is implicated in diseases such as multiple sclerosis, inflammatory diseases, myocardial infarction, retinal degeneration, depression, and potentially cancer.
Gs protein activation leading to increased cAMP production
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor 65 (GPR65).